Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-009533
Filing Date
2015-02-17
Accepted
2015-02-17 09:56:00
Documents
13
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q v401132_10q.htm 10-Q 316357
2 EXHIBIT 10.5 v401132_ex10-5.htm EX-10.5 17891
3 EXHIBIT 10.6 v401132_ex10-6.htm EX-10.6 18068
4 EXHIBIT 31.1 v401132_ex31-1.htm EX-31.1 10554
5 EXHIBIT 31.2 v401132_ex31-2.htm EX-31.2 9710
6 EXHIBIT 32.1 v401132_ex32-1.htm EX-32.1 4805
7 EXHIBIT 32.2 v401132_ex32-2.htm EX-32.2 5697
  Complete submission text file 0001144204-15-009533.txt   4624470

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ppch-20141231.xml EX-101.INS 535528
9 XBRL TAXONOMY EXTENSION SCHEMA ppch-20141231.xsd EX-101.SCH 43514
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ppch-20141231_cal.xml EX-101.CAL 33294
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ppch-20141231_def.xml EX-101.DEF 264073
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ppch-20141231_lab.xml EX-101.LAB 288362
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ppch-20141231_pre.xml EX-101.PRE 295748
Mailing Address PO BOX 114 CAMBERWELL, VICTORIA C3 3124
Business Address PO BOX 114 CAMBERWELL, VICTORIA C3 3124 61 3 9208 4128
Propanc Health Group Corp (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 15618647
SIC: 2834 Pharmaceutical Preparations